Edition:
India

People: Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

27.72USD
3 Aug 2020
Change (% chg)

$1.83 (+7.07%)
Prev Close
$25.89
Open
$26.28
Day's High
$27.82
Day's Low
$26.28
Volume
403,408
Avg. Vol
353,482
52-wk High
$45.02
52-wk Low
$16.86

Chan, Gerald 

Dr. Gerald Chan Ph.D. serves as Independent Chairman of the Board of the Company. Dr. Chan co-founded Morningside Venture Investments, Ltd., or Morningside, a private investment group with venture, private equity and property investments, in 1986. He chairs the strategic advisory board of the Morningside Center for Innovative and Affordable Medicine at Emory University. He has served as a member of Scientific Advisory Committee of Brigham and Women’s Hospital since 2018, the Global Advisory Council of Harvard University since 2012 and the Dean’s Board of Advisors of the Harvard T.H. Chan School of Public Health since 2011. He has served as trustee of Scripps Research Institute since 2016. Dr. Chan serves on the board of directors of Stealth BioTherapeutics Corp. and Hang Lung Group Limited. He previously chaired the Innovation Advisory Committee of Wellcome Trust from 2016 until 2020 and served as a director of Aduro Biotech Inc. from 2014 to 2018. Dr. Chan received his B.S. and M.S. degrees in engineering from the University of California, Los Angeles, and his Master’s degree in medical radiological physics and Doctor of Science degree in radiation biology from Harvard University. He did his post-doctoral training at the Dana-Farber Cancer Institute. Dr. Chan was elected to membership in the American Academy of Arts and Sciences in 2017. We believe that Dr. Chan is qualified to serve on our board of directors because of his extensive experience in life science investments and serving on boards of directors.

Basic Compensation

Total Annual Compensation, USD 76,750
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 183,535
Fiscal Year Total, USD 260,285

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gerald Chan

260,285

Cedric Francois

4,267,180

Pascal Deschatelets

1,821,230

Timothy Sullivan

1,719,300

Victoria Brown

--

Thomas Lackner

2,108,720
As Of  31 Dec 2019